Your Guide to Severe Refractory Eosinophilic Asthma
At a Glance
Severe refractory eosinophilic asthma is a specific type of asthma driven by Type 2 inflammation that does not respond to standard inhaled steroids. Patients often require targeted biologic therapies to control their symptoms and reduce their dependence on oral steroids like prednisone.
Welcome to your comprehensive guide on Severe Refractory Eosinophilic Asthma. Receiving this diagnosis—or suspecting you might have it—can be overwhelming. This guide is designed to empower you with the knowledge you need to partner effectively with your medical team.
Severe refractory eosinophilic asthma is a specific subset of asthma driven by an overactive immune response known as Type 2 inflammation. [1] Unlike standard asthma, it remains uncontrolled despite high doses of inhaled steroids, often leaving patients reliant on harmful oral steroids like prednisone. [2]
In this resource, you will find detailed, evidence-based information across four key areas:
Validation & Orientation: Understanding Severe Refractory Eosinophilic Asthma
Learn what severe refractory eosinophilic asthma means. Understand the role of eosinophils, the risks of steroid dependence, and modern biologic treatments.
Biology & Differential Diagnosis: Eosinophils, IL-5, and The EGPA Pitfall
Learn the biology behind severe eosinophilic asthma, including the role of IL-5. Understand the red flag symptoms of EGPA and why it gets misdiagnosed.
Standard of Care Treatment: Biologics and GINA Guidelines
Learn about biologic treatments for severe eosinophilic asthma based on GINA guidelines. Understand your options, side effects, and steroid tapering safely.
Monitoring, Biomarkers & What to Expect: Tracking Your Asthma
Learn how to track severe eosinophilic asthma using biomarkers like blood eosinophil counts and FeNO tests. Understand your path to clinical remission.
Use this guide to learn at your own pace, prepare for your next specialist visit, and confidently advocate for your health.
Common questions in this guide
What is severe refractory eosinophilic asthma?
Why do standard asthma inhalers not work for my severe asthma?
How do biologic therapies treat eosinophilic asthma?
How will my doctor monitor my severe asthma over time?
What is EGPA and how does it relate to my asthma?
Related questions
Get notified when new evidence is published on Severe Refractory Eosinophilic Asthma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (2)
- 1
Characteristics, phenotypes, mechanisms and management of severe asthma.
Chung KF, Dixey P, Abubakar-Waziri H, et al.
Chinese medical journal 2022; (135(10)):1141-1155 doi:10.1097/CM9.0000000000001990.
PMID: 35633594 - 2
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.
Pelaia C, Vatrella A, Busceti MT, et al.
Drug design, development and therapy 2017; (11()):3137-3144 doi:10.2147/DDDT.S150656.
PMID: 29133975
This guide is for informational purposes only and does not replace professional medical advice. Always consult your pulmonologist or allergist before making any changes to your asthma treatment plan.